Kim C. de Vries

About

Kim C. de Vries is a leading researcher in radiation oncology, specializing in advanced treatment planning and optimization for robotic radiotherapy. Her work focuses on enhancing the precision and efficiency of stereotactic body radiation therapy (SBRT) and brachytherapy, particularly for prostate, lung, and breast cancers. A major contribution is the development and validation of VOLO™, a novel optimizer for CyberKnife MLC-based planning, which she showed can achieve largely reduced organ-at-risk (OAR) doses while cutting planning and delivery times for challenging SBRT cases—a breakthrough detailed in her 2021 paper (14 citations). She also pioneered fully automated treatment planning with prioritized multicriterial optimization and beam angle optimization (AUTO BAO), enabling noncoplanar MLC-based robotic radiotherapy with enhanced efficiency (12 citations). In breast cancer, de Vries leads a randomized controlled trial testing hyaluronic acid spacer injections to reduce skin toxicity in accelerated partial breast irradiation (APBI) (6 citations), addressing a critical clinical need. Her work, cited over 30 times, is shaping the future of automated, patient-specific radiotherapy, making complex treatments faster, safer, and more accessible.

Research Focus

Key Achievements

Top Papers

1. 1
   Largely reduced OAR doses, and planning and delivery times for challenging robotic SBRT cases, obtained with a novel optimizer

   14 citations · 2021
2. 2
   Fully automated treatment planning for MLC‐based robotic radiotherapy

   12 citations · 2021
3. 3
   A randomized controlled trial testing a hyaluronic acid spacer injection for skin toxicity reduction of brachytherapy accelerated partial breast irradiation (APBI): a study protocol

   6 citations · 2018

Key Collaborators

Contact & Links